Livingston, NJ, United States of America

Xin-Jie Chu

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 112(Granted Patents)


Location History:

  • Livingston, NJ (US) (2003 - 2013)
  • Shanghai, CN (2015 - 2018)

Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Innovations of Xin-Jie Chu: A Pioneer in HIV Research

Introduction: Xin-Jie Chu, based in Livingston, NJ, is a distinguished inventor known for his significant contributions in the field of pharmaceutical sciences. With an impressive portfolio of 21 patents, he has made remarkable strides in developing innovative solutions for combating HIV.

Latest Patents: Among his latest inventions are piperazine derivatives, which have been designed as HIV protease inhibitors. These compounds, outlined in his patent documents, demonstrate a novel approach towards the inhibition of HIV protease. The pharmaceutical compositions comprising these piperazine derivatives not only aim to inhibit HIV replication but also provide strategies for the prophylaxis and treatment of HIV infections, as well as delaying the onset or progression of AIDS.

Career Highlights: Xin-Jie Chu has worked with prominent organizations such as Hoffmann-La Roche Inc. and Merck Sharp & Dohme Corporation. His expertise and innovative mindset have been instrumental in advancing research initiatives aimed at addressing critical health challenges associated with HIV.

Collaborations: Throughout his career, Xin-Jie has collaborated with talented individuals like David Joseph Bartkovitz and Qingjie Ding. These partnerships have fostered a dynamic environment for research and innovation, contributing to the development of impactful pharmaceutical inventions.

Conclusion: Xin-Jie Chu's contributions to the field of HIV research with his groundbreaking patents exemplify the transformative power of innovation in pharmaceutical sciences. His work not only enhances our understanding of HIV protease inhibition but also plays a vital role in developing potential treatments for HIV and AIDS, highlighting his position as a leading inventor in this critical area of health research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…